Ashmilro Engineering Limited: Lead Time Reduction Custom Case Solution & Analysis

Part 1: Evidence Brief (Case Researcher)

Financial Metrics

• Annual Revenue: $42M (Exhibit 1).
• Operating Margin: 8.4% (Exhibit 1).
• Inventory Turnover: 4.2x, significantly below industry benchmark of 6.5x (Exhibit 2).
• Cost of Quality: 6.2% of total production costs (Exhibit 3).

Operational Facts

• Lead Time: 14 weeks average; 9 weeks manufacturing, 5 weeks transit/logistics (Para 4).
• Capacity Utilization: 68% on primary assembly lines (Exhibit 4).
• Work-in-Progress (WIP): $8.4M tied up in shop floor inventory (Exhibit 2).
• Production Process: Batch-and-queue model with manual scheduling (Para 9).

Stakeholder Positions

• CEO (Marcus Thorne): Demands 50% reduction in lead time to prevent contract loss with key account, Aerotech.
• COO (Sarah Jenkins): Advocates for JIT implementation; warns of current high setup times (4 hours average).
• Production Manager (David Chen): Resists changes; argues that current batch sizes optimize machine utilization.

Information Gaps

• Detailed breakdown of downtime causes (scheduled vs. unscheduled).
• Specific penalty clauses in the Aerotech contract.
• Skill level assessment of floor staff regarding cross-training for cell-based manufacturing.

Part 2: Strategic Analysis (Strategic Analyst)

Core Strategic Question

How can Ashmilro reduce total lead time by 50% without triggering a collapse in manufacturing stability or excessive capital expenditure?

Structural Analysis

The core issue is a misalignment between production scheduling and customer delivery requirements. The current batch-and-queue system prioritizes machine utilization over flow, creating massive WIP and extended wait times.

Strategic Options

• Option 1: Cellular Manufacturing Transition. Shift from functional departments to product-focused cells. Trade-offs: High initial training costs; significant disruption to existing workflows. Resources: Reconfiguration of floor layout and multi-skilling training.
• Option 2: Setup Time Reduction (SMED). Focus exclusively on reducing the 4-hour setup time to allow for smaller batches. Trade-offs: Lower impact on overall lead time compared to cellular layout; high reliance on operator discipline. Resources: SMED workshops and tooling investment.
• Option 3: Inventory Buffer Strategy. Maintain higher finished goods stock for Aerotech. Trade-offs: Increases working capital pressure; does not solve root cause of production inefficiency. Resources: Capital for increased holding costs.

Preliminary Recommendation

Adopt Option 1 combined with targeted SMED initiatives. This addresses the structural flow problem rather than merely managing the symptoms via inventory.

Part 3: Implementation Roadmap (Operations Planner)

Critical Path

1. Phase 1 (Weeks 1-4): Pilot cellular layout on one production line.
2. Phase 2 (Weeks 5-8): SMED training and execution for the pilot line.
3. Phase 3 (Weeks 9-12): Measure throughput and quality; refine standard work documentation.
4. Phase 4 (Weeks 13-24): Full-scale rollout across remaining lines.

Key Constraints

• Cultural Resistance: The Production Manager’s focus on machine utilization is the primary barrier.
• Skill Gaps: Current operators are specialized; cross-training is mandatory for cell flexibility.

Risk-Adjusted Implementation

Maintain a 15% safety stock of critical components during the transition to mitigate potential output drops during the first 90 days. If the pilot fails to show a 20% lead time reduction by week 10, revert to batch scheduling while refining SMED tools.

Part 4: Executive Review (Executive Critic)

BLUF

Ashmilro must transition to a cellular manufacturing model immediately. The current batch-and-queue operation is optimized for a defunct production logic that ignores the cost of time. Management is currently prioritizing machine utilization over customer satisfaction, which threatens the Aerotech account. The proposed plan to reconfigure the floor layout is the only viable path to hitting the 50% lead time reduction target. Implementation will fail if the Production Manager is not incentivized on throughput rather than individual machine efficiency. The focus must shift from keeping machines running to keeping products moving.

Dangerous Assumption

The analysis assumes the workforce can transition to multi-skilled roles within the proposed 24-week window without significant attrition or labor disputes.

Unaddressed Risks

• Quality Volatility: Moving to new, unproven cell layouts often yields a short-term spike in defects.
• Supply Chain Fragility: If upstream suppliers cannot match the new, smaller, more frequent delivery cadence, the cellular model will starve for components.

Unconsidered Alternative

Outsource the non-core assembly steps that contribute most to the 14-week lead time, effectively shrinking the internal production scope to focus exclusively on high-value components.

Verdict

APPROVED FOR LEADERSHIP REVIEW